Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Geheime Uran-Aktie: Ist das der historische "New Deal"-Moment für amerikanischen Uransektor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ATTS | ISIN: US4500561067 | Ticker-Symbol: I25
Tradegate
03.09.25 | 09:01
145,00 Euro
-1,36 % -2,00
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
IRHYTHM TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
IRHYTHM TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
145,00148,0012:15
145,00148,0010:35

Aktuelle News zur IRHYTHM TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FriRhythm data highlights increased AFib detection with Zio long-term continuous monitoring4
IRHYTHM TECHNOLOGIES Aktie jetzt für 0€ handeln
FrAMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service715Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA).AMALFI...
► Artikel lesen
22.08.Solid Earnings Lifted iRhythm Technologies (IRTC) in Q25
20.08.iRhythm up on Buy coverage at BofA on market expansion opportunities2
20.08.Where iRhythm Technologies Stands With Analysts1
20.08.BofA Securities initiates coverage on iRhythm Technologies stock with Buy rating3
18.08.Investor Short Report Flags Steep Downside Risk For iRhythm Technologies2
18.08.iRhythm stock falls after Spruce Point issues short report1
18.08.AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm's Zio LTCM Clinical Superiority104In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis,...
► Artikel lesen
01.08.Breaking Down iRhythm Technologies: 4 Analysts Share Their Views1
01.08.iRhythm inks AI-powered arrhythmia detection partnership with Lucem Health, reports strong Q27
01.08.IRhythm raises 2025 revenue outlook to up to $730M as core and innovative channels accelerate3
31.07.iRhythm Tech: EPS übertrifft Schätzungen um 0,19 $ - Umsatz besser als erwartet4
31.07.iRhythm Technologies, Inc. - 10-Q, Quarterly Report2
31.07.iRhythm Technologies Announces Second Quarter 2025 Financial Results266SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
► Artikel lesen
31.07.iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions1
31.07.iRhythm Technologies, Inc. - 8-K, Current Report1
30.07.iRhythm Technologies Q2 2025 Earnings Preview1
17.07.iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 20251
11.07.Integer appoints former iRhythm CEO to board2
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1